BSE filing, NSE: SOMDUTTFIN. Summary written from the filing by ALFA Finder's alert engine.
Crescentis Capital Ltd: key numbers
- Share price
- ₹101.00
- Market cap
- ₹171.8 Cr
- Revenue (annual)
- ₹1.48 Cr
- Net profit (annual)
- ₹-2.53 Cr
- P/E (TTM)
- 145.9×Sector 19.7×
- Promoter holding
- 74.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crescentis Capital Ltd
All →Crescentis Capital Board Meeting Date
Crescentis Capital will hold a Fund-Raising Committee meeting on 29 October 2026 to approve the terms of a proposed rights issue of up to Rs 80 crore. The filing is a prior intimation of that committee meeting.
Crescentis Capital Other Announcement
Crescentis Capital Limited submitted the Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, as per SEBI regulations.
Crescentis Capital Employee Stock Options
Crescentis Capital Limited granted 5,00,000 stock options to its Managing Director, Mr. Subba Rao Veeravenkata Meka, under the company's 2025 ESOS scheme.
Crescentis Capital Fund Raise of ₹80 Cr
Crescentis Capital Limited's board has approved a rights issue of equity shares for up to Rs 80 Crore. The board also approved the Draft Letter of Offer.
- Value
- ₹80.00 Cr
Crescentis Capital Board Meeting Date
Crescentis Capital will hold a board meeting on September 29, 2026, to discuss progress on its proposed rights issue of equity shares.
Crescentis Capital Annual General Meeting
Crescentis Capital Limited conducted its 33rd Annual General Meeting on August 26, 2026. The meeting transacted key business, including director reappointments and ESOP plan approvals.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.